How Gut Bacteria Determine Bone Marrow Transplant Survival Odds
A landmark review reveals how microbiome disruption before and after stem cell transplants drives deadly graft-versus-host disease.
20 articles
A landmark review reveals how microbiome disruption before and after stem cell transplants drives deadly graft-versus-host disease.
New research shows integrated HBV DNA โ not active viral replication โ is the dominant source of surface antigen in HBeAg-negative chronic hepatitis B.
Researchers develop 22-color flow cytometry to profile unconventional T cells that protect gut health and maintain immune balance.
Study reveals how IL-6 inflammation protein fuels liver cancer growth and identifies potential therapeutic vulnerability.
New research reveals how certain immune cells create alternative blood vessels that fuel pancreatic cancer growth and spread.
Aged mouse colons get stuck in a fetal-like repair mode that makes them hypersensitive to immune attack, derailing gut healing after injury.
New research reveals how the gut's portal blood environment primes neutrophils to drive inflammation and damage in remote organs.
A comprehensive review maps the full immunopathology of IBD, linking cytokine cascades, barrier dysfunction, and emerging biomarkers to diagnosis and treatment.
Scientists propose integrated approach connecting cellular aging, gut bacteria, and tumor environment to improve cancer prevention and treatment.
Scientists develop scBPS tool to identify which human cells interact with specific gut microbes, revealing new therapeutic targets.
Bacterial metabolite from flavonoids protects against graft-versus-host disease while preserving anti-cancer effects in stem cell transplants.
New research shows blocking PKM2 in immune cells promotes gut healing in colitis while preventing tumor formation.
Age-related shifts in intestinal T cell populations may silently erode gut barrier function, accelerating the chronic inflammation that drives aging diseases.
A new review links adult cholestasis to pediatric genetic syndromes, opening doors to targeted therapies including novel bile acid transport inhibitors.
New research reveals gut microbes orchestrate a 3-day vitamin A relay from gut cells to immune cells, programming intestinal immunity.
A 13-year UK analysis of 273 liver transplant patients finds HBIG maintenance may be unnecessary, with NA-only prophylaxis offering a cost-effective alternative.
New review reveals how gut microbe chemicals directly reprogram tumor immune responses through multiple pathways.
Comprehensive molecular analysis reveals complex host-microbiome interactions driving gastric cancer development and progression.
New research questions whether long-term HBIG therapy is necessary after liver transplantation, potentially simplifying post-transplant care.
Western diets reduce microbial diversity in Lynch syndrome, while plant proteins boost beneficial bacteria linked to colorectal cancer protection.